Celebrating 50 Years of Impact and Innovation


Touro will celebrate its 50th anniversary with a gala on Sunday, December 4, at 4 p.m., at the New York Marriott Marquis in New York City. It will mark the university’s “50 years of impact and innovation.”

Honorees are Dr. Alan Kadish, president of the Touro University System; Dovid Lichtenstein, Touro board member, entrepreneur, and real estate investor; Dr. Robert Goldschmidt, Touro vice president, and Lander executive dean; and Shelley Berkley, Touro senior vice president, and former Nevada congresswoman. An honorary doctorate will go to Dr. Albert Bourla, Pfizer’s chairman and CEO, who oversaw the creation and production of the covid vaccine.

Academic Convocation

As we celebrate our 50th anniversary we also mark the singular achievement of our rise to university status with a historic academic convocation. As part of the convocation ceremony, an honorary doctorate will be bestowed upon:

Albert Bourla, D.V.M., Ph.D., leads Pfizer in its purpose— breakthroughs that change patients’ lives, with a focus on driving the scientific and commercial innovation needed to have a transformational impact on human health.

During his more than 25 years at Pfizer, Dr. Bourla has built a diverse and successful career. When he took the reins as CEO in January 2019, Dr. Bourla accelerated Pfizer’s transformation to become a more science-driven, innovative company.

Under his leadership, Pfizer invested more than $2 billion dollars at risk, and Dr. Bourla inspired colleagues to deliver a safe and effective vaccine for COVID-19 in just eight months—a process that typically takes eight to ten years— without compromising quality or integrity. A year later, Pfizer delivered the first FDA-authorized oral antiviral treatment for COVID-19.

For more information, call (855) 33-TOURO or go to 50.Touro.edu/gala.

New York Jewish Guide

Leave a Reply

Your email address will not be published. Required fields are marked *